Lymphomas/CLL

John M. Burke MD and Christopher R. Flowers MD review and share their expert perspectives on key findings in lymphoma/CLL presented at the 2017 ASH annual meeting.

Share

Supporters

AbbVie

AstraZeneca

Celgene

Genentech TEXT Only

Janssen Biotech Pharmacyclics Abbvie

Jazz Pharmaceuticals, Inc.

Novartis Pharmaceuticals Corporation

Pharmacyclics Inc

Seagen

Takeda Oncology